Meningoradiculitis due to varicella zoster virus reactivation in a patient treated with ixekizumab

Psoriasis

SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor

J Eur Acad Dermatol Venereol.

Balestri R, Rech G, Girardelli CR

doi: 10.1111/jdv.16571.

Melanoma and Skin Cancer

Hemophagocytic lymphohistiocytosis of a melanoma patient under BRAF/MEK-inhibitor therapy following anti-PD1 inhibitor treatment: a case report and review to the literature

Melanoma Res.

Dudda M, Mann C, Heinz J, Schmidgen I, Weid F, Kühn M, Saloga J, Grabbe S, Loquai C

doi: 10.1097/CMR.0000000000000703.Visit the original publication at ncbi.nlm.nih.gov

Melanoma and Skin Cancer

Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitors

Melanoma Res.

Thummalapalli R, Melms JC, Mier J, Izar B

doi: 10.1097/CMR.0000000000000646.

Systemic Lupus Erythematosus

Successful treatment of refractory systemic lupus erythematosus using proteasome inhibitor bortezomib followed by belimumab: description of two cases

Lupus.

Sjöwall C, Hjorth M, Eriksson P

doi: 10.1177/0961203317691371.

Melanoma and Skin Cancer

Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors

Br J Dermatol.

Gault A, Anderson AE, Plummer R, Stewart C, Pratt AG, Rajan N

doi: 10.1111/bjd.19750.Visit the original publication at ncbi.nlm.nih.gov

PsoriasisGout

Chronic tophaceous gout in patients with psoriasis

An Bras Dermatol.

Lobato LC, Coutinho JC, Frota MZ, Schettini AP, Santos M

doi: 10.1590/

Melanoma and Skin CancerImmunotherapy

Guillain-Barré Syndrome Triggered by Immune Checkpoint Inhibitors: A Case Report and Literature Review

J Clin Neuromuscul Dis.

Supakornnumporn S, Katirji B

doi: 10.1097/ CND.0000000000000193.

A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies

Mult Scler Relat Disord.

Marangi A, Gajofatto A, Marastoni D, Gobbin F, Guiotto F, Tonin P, Benedetti MD

doi: 10.1016/j.msard.2017.11.015.

Psoriasis

Durable Resolution of Severe Psoriasis in a Patient Treated with Pentostatin for Hairy Cell Leukemia: A Case Report

Dermatol Ther (Heidelb).

Alsuliman T, Lassoued K, Belghoul M, Debbache K, Choufi B

doi: 10.1007/s13555-017-0216-z.

Related content

SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor

Hemophagocytic lymphohistiocytosis of a melanoma patient under BRAF/MEK-inhibitor therapy following anti-PD1 inhibitor treatment: a case report and review to the literature

Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitors

Successful treatment of refractory systemic lupus erythematosus using proteasome inhibitor bortezomib followed by belimumab: description of two cases

Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors

Chronic tophaceous gout in patients with psoriasis

Guillain-Barré Syndrome Triggered by Immune Checkpoint Inhibitors: A Case Report and Literature Review

A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies

Durable Resolution of Severe Psoriasis in a Patient Treated with Pentostatin for Hairy Cell Leukemia: A Case Report